{"id":1068460,"date":"2024-02-14T02:39:26","date_gmt":"2024-02-14T07:39:26","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/santhera-announces-publication-of-efficacy-safety-and-tolerability-data-with-vamorolone-agamree-in-patients-with-duchenne-muscular-dystrophy-in\/"},"modified":"2024-08-18T11:47:36","modified_gmt":"2024-08-18T15:47:36","slug":"santhera-announces-publication-of-efficacy-safety-and-tolerability-data-with-vamorolone-agamree-in-patients-with-duchenne-muscular-dystrophy-in","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/santhera-announces-publication-of-efficacy-safety-and-tolerability-data-with-vamorolone-agamree-in-patients-with-duchenne-muscular-dystrophy-in.php","title":{"rendered":"Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE\u00ae) in Patients with Duchenne Muscular Dystrophy in&#8230;"},"content":{"rendered":"<p><![CDATA[Pratteln, Switzerland, February\u00a014, 2024 \u2013 Santhera Pharmaceuticals (SIX: SANN) announces the publication of the paper \u201cEfficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy\u201d in the peer-reviewed journal Neurology [2]. The publication reports the results of the 48-week treatment with vamorolone in patients with DMD in the VISION-DMD study, supporting the long-term efficacy and safety profile of vamorolone and concluding that vamorolone was generally well tolerated, consistent with the 24-week study findings, as published previously in JAMA Neurology [3].]]><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/02\/14\/2828764\/0\/en\/Santhera-Announces-Publication-of-Efficacy-Safety-and-Tolerability-Data-with-Vamorolone-AGAMREE-in-Patients-with-Duchenne-Muscular-Dystrophy-in-Neurology.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE\u00ae) in Patients with Duchenne Muscular Dystrophy in...\">Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE\u00ae) in Patients with Duchenne Muscular Dystrophy in...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See original here: Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE\u00ae) in Patients with Duchenne Muscular Dystrophy in... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/santhera-announces-publication-of-efficacy-safety-and-tolerability-data-with-vamorolone-agamree-in-patients-with-duchenne-muscular-dystrophy-in.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068460","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068460"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068460"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068460\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}